Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.

Contributed by: GlobeNewswire

Tags

Nanobiotix

More Like This

Evaxion Announces Closing of $15 Million Public Offering

PR Newswire associated0

Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing

Evaxion Biotech Announces Pricing of $15 Million Public Offering

ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA

Evaxion Biotech Announces Closing of Private Placement

NuCana Prices $7 Million Registered Direct Offering

GlobeNewswire associated0

Development Bank of Japan invests in 4BIO Capital’s Ventures III fund

Evaxion Biotech Announces Private Placement Financing